Continuous Bladder Irrigation Devices Market Report: Market Size & Forecast 2026

Continuous bladder irrigation devices are primarily used to prevent clot retention and maintain catheter patency after transurethral surgeries, particularly for bladder, prostate, and kidney procedures. The market demonstrates steady expansion, with global revenues estimated between $1.42 billion and $1.49 billion in 2025 depending on methodology and product scope. Across multiple industry analyses, forecasts converge on a mid-4-percent to 5-percent CAGR through the early 2030s, positioning the market to approach approximately $1.87 billion by 2030.

• •Market valued at approximately $1.42-1.49 billion in 2025 across independent industry analyses
• •Projected CAGR of 4.23% to 5.5% through 2030-2034, with a consensus midpoint around 4.7%
• •Regulatory approval and device safety standards overseen by agencies including the U.S. Food and Drug Administration (FDA)
• •Part of the broader urology devices market estimated at $39 billion in 2025

The rising global prevalence of urological conditions, including benign prostatic hyperplasia, bladder cancer, and urinary tract disorders, directly increases demand for surgical interventions requiring bladder irrigation. An aging demographic profile amplifies this trend, as older populations face elevated risks of urological complications and postoperative clot retention. Hospital infrastructure expansion in emerging economies, coupled with increasing procedural volumes in established markets, continues to support market expansion.

• •Aging global population driving higher incidence of urological conditions requiring surgical intervention
• •Increasing adoption of minimally invasive urological procedures generating demand for post-operative irrigation
• •Growing healthcare infrastructure and procedural volumes in Asia-Pacific and Latin American markets

North America historically represents the largest regional market, supported by advanced healthcare infrastructure, high procedural volumes, and favorable reimbursement frameworks for urological devices. Europe follows as the second-largest region, with Western European markets showing consistent demand. The Asia-Pacific region is identified as the fastest-growing segment, fueled by rising healthcare access, increasing urological disease burden, and expanding hospital networks in countries including China, India, and Southeast Asian nations.

• •North America holds the dominant market share, supported by established healthcare systems and high surgical procedure rates
• •Asia-Pacific emerging as the fastest-growing regional market, driven by healthcare infrastructure development and rising disease prevalence
• •Product segments span 3-way Foley catheters, dedicated irrigation sets, and associated pumping systems

What are the recent trends and outlook?

Technological innovation is increasingly focused on antimicrobial and hydrophilic coatings designed to reduce catheter-associated infections and improve patient comfort. The broader continence care market, which overlaps with irrigation devices, is projected to surpass $4.6 billion by 2035, indicating substantial adjacent growth potential. Over the medium term, the market is expected to maintain its steady 4-to-5-percent annual growth trajectory, supported by demographic trends and expanding access to urological care across developing regions.

• •Antimicrobial and hydrophilic catheter technologies gaining adoption to reduce infection-related complications
• •Adjacent continence care market expected to exceed $4.6 billion by 2035, signaling expanded product opportunities
• •Market anticipated to reach approximately $1.87 billion by 2030 under prevailing growth assumptions